Switch Language
Alt tag

See Also

Peripheral Artery Disease: causes and consequences

Coronary Artery Disease: causes and consequences

Thrombosis Digest 2020

When is the right time to start thinking about renal function in patients with AF?

When is the right time to start thinking about renal function in patients with AF?

When is the right time to start thinking about renal function in patients with AF?

Thrombosis Adviser at the European Society of Cardiology Congress 2020

Thrombosis Adviser at the European Society of Cardiology Congress 2020

Thrombosis Adviser at the European Society of Cardiology Congress 2020

Extended Treatment for VTE: Tailoring Treatment for Patients Who Need it

Extended Treatment for VTE: Tailoring Treatment for Patients Who Need it

Extended Treatment for VTE: Tailoring Treatment for Patients Who Need it

Patients with diabetes and atrial fibrillation: How can the risk of cardiovascular death be reduced?

Patients with diabetes and atrial fibrillation: How can the risk of cardiovascular death be reduced?

Patients with diabetes and atrial fibrillation: How can the risk of cardiovascular death be reduced?

Managing anticoagulation during the COVID-19 pandemic

Managing anticoagulation during the COVID-19 pandemic

Managing anticoagulation during the COVID-19 pandemic

Supporting the treatment of patients with low-risk pulmonary embolism at home

Supporting the treatment of patients with low-risk pulmonary embolism at home

Supporting the treatment of patients with low-risk pulmonary embolism at home

The importance of real-world evidence: A look at stroke prevention in atrial fibrillation

The importance of real-world evidence: A look at stroke prevention in atrial fibrillation

The importance of real-world evidence: A look at stroke prevention in atrial fibrillation

Keeping it simple: Single drug approaches to VTE treatment

Keeping it simple: Single drug approaches to VTE treatment

Keeping it simple: Single drug approaches to VTE treatment

The importance of preserving kidney function in atrial fibrillation

The importance of preserving kidney function in atrial fibrillation

The importance of preserving kidney function in atrial fibrillation

Where next in cancer-associated thrombosis?

Where next in cancer-associated thrombosis?

Where next in cancer-associated thrombosis?

Time for a change? Switching anticoagulants in patients with AF or VTE

Time for a change? Switching anticoagulants in patients with AF or VTE

Time for a change? Switching anticoagulants in patients with AF or VTE

High-risk patients with atrial fibrillation: The importance of protection

High-risk patients with atrial fibrillation: The importance of protection

High-risk patients with atrial fibrillation: The importance of protection

Understanding the risk of VTE recurrence: Who needs extended anticoagulation?

Understanding the risk of VTE recurrence: Who needs extended anticoagulation?

Understanding the risk of VTE recurrence: Who needs extended anticoagulation?

ESC Heart and Stroke Conference: Highlights from Bayer 24–25 January 2020

ESC Heart and Stroke Conference: Highlights from Bayer 24–25 January 2020

ESC Heart and Stroke Conference: Highlights from Bayer 24–25 January 2020

Venous protection in 2019: A year in review

Venous protection in 2019: A year in review

Venous protection in 2019: A year in review

Stroke prevention in patients with AF in 2019: A year in review

Stroke prevention in patients with AF in 2019: A year in review

Stroke prevention in patients with AF in 2019: A year in review

Never miss out on the latest news!

Over 4,000 healthcare professionals have already signed up.

The next Bayer sponsored ESC-EHRA Webinar is just ahead of us and will already take place next week. Tuesday May 11, 2021 from 18:00 to 19:00 CEST

Join Prof. Roxana Mehran, Dr. Marcelo Sanmartin Fernandez and Prof. Davide Capodanno in the discussion on the topic “Management of atrial fibrillation patients undergoing PCI: where are we now?”